Media

Strongbridge Biopharma plc Announces Proposed Public Offering of Ordinary Shares

MIPS: Invitation to the presentation of the results for the period January – June 2018

Notice of Nexstim Plc’s Half-Yearly Report H1 2018

Strongbridge Biopharma plc Announces Positive Top-Line Results from the Pivotal Phase 3 SONICS Study of RECORLEV™ (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome

Strongbridge Biopharma plc Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Nordic Nanovector ASA: Invitation to Second Quarter and First Half 2018 Results Presentation and Webcast

Altimmune to Announce Second Quarter 2018 Financial Results on August 15

BONESUPPORT Signs Agreement with MTF Biologics to Expand US Product Offering

BONESUPPORT HOLDING AB (publ) – Interim Report